State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Department of Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
Department of Oncology, Hangzhou Bay Hospital, Ningbo, Zhejiang 315300, China.
Discov Med. 2021 Sep-Oct;32(166):65-78.
The definition of multiple primary malignant tumors (MPMT) is two or more cancers without any correlation occur in an individual.
This study is to delineate clinical characteristics of patients with MPMT and explore the treatment strategies for these patients.
This retrospective study analyzed the information of MPMT patients collected from two databases from January 2017 to September 2020. R tool and SPSS were used for statistical analysis.
The cohort consisted of a total of 213 patients (male:female ratio 1.17:1) with MPMT. Among them, 159 patients had metachronous multiple primary malignant tumors (mMPMT), and 54 had synchronous multiple primary malignant tumors (sMPMT). The age at the time of diagnosis for most of them was 61-70 years. For mMPMT, the most common primary cancers were of digestive, breast, and lung origins, while the secondary ones were of digestive, lung, and urinary origins. For sMPMT patients, the most occurrences were digestive cancers in different organs of the digestive system. The most common pathological type of both primary and secondary cancers was adenocarcinoma. In this study, 54.92% of MPMT patients experienced treatments in addition to the surgical treatment, including targeted therapy and anti-PD-1 immunotherapy. The median survival time was 234.97 months, and the 5-year survival rate was 79% of all patients. The classification of MPMT and the age when the first primary cancer was diagnosed were independent factors affecting the prognosis of MPMT.
Clinical characteristics of patients with sMPMT and mMPMT were different. Patients with cancer need primary cancer surveillance and screening of other cancers.
多原发恶性肿瘤(MPMT)的定义为个体中发生的两个或多个无任何关联的癌症。
本研究旨在描述 MPMT 患者的临床特征,并探讨这些患者的治疗策略。
本回顾性研究分析了 2017 年 1 月至 2020 年 9 月从两个数据库收集的 MPMT 患者信息。使用 R 工具和 SPSS 进行统计分析。
该队列共包括 213 例 MPMT 患者(男:女比为 1.17:1)。其中 159 例为异时性多原发恶性肿瘤(mMPMT),54 例为同时性多原发恶性肿瘤(sMPMT)。大多数患者的诊断年龄为 61-70 岁。对于 mMPMT,最常见的原发性癌症来自消化系统、乳腺和肺部,而继发性癌症则来自消化系统、肺部和泌尿系统。对于 sMPMT 患者,最常见的是消化系统不同器官的癌症。原发性和继发性癌症最常见的病理类型是腺癌。在本研究中,54.92%的 MPMT 患者除手术治疗外还接受了其他治疗,包括靶向治疗和抗 PD-1 免疫治疗。中位生存时间为 234.97 个月,所有患者的 5 年生存率为 79%。MPMT 的分类和首次诊断原发性癌症的年龄是影响 MPMT 预后的独立因素。
sMPMT 和 mMPMT 患者的临床特征不同。患有癌症的患者需要对原发性癌症进行监测和筛查其他癌症。